Overview

Seasonal Affective Disorder Market is poised to value over USD 930 billion by 2027 end at a CAGR of over 5.5% during the forecast period 2020 to 2027.

Seasonal affective disorder is a kind of depression that can occur during a particular season. It mostly occurs to people in the winter, but it is possible to occur during summers as well. It is commonly found in women and people between the age of 15 to 55. Growing awareness regarding mental health, especially depression is some of the factors responsible for the growth of the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Seasonal Affective Disorder Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Seasonal Affective Disorder Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Seasonal Affective Disorder Market:

  • AbbVie Inc. (US)
  • Allergan (Republic of Ireland)
  • Bayer AG (Germany)
  • Bristol-Myers Squibb Company (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Henry Schein Inc. (US)
  • Pfizer Inc. (US)

(Note: The list of the major players will be updated with the latest market scenario and trends)

Seasonal Affective Disorder Market

Seasonal Affective Disorder Market Segmentation:

By Type

  • Fall and winter SAD
  • Spring and summer SAD
  • Others

By Diagnosis

  • Physical Exam
  • Lab Tests
  • Complete Blood Count (CBC)
  • Thyroid Blood Tests
  • Others
  • Psychological Evaluation
  • Intelligence Tests
  • Personality Tests
  • Attitude Tests
  • Achievement Tests
  • Neuropsychological Tests
  • Vocational Tests
  • Direct Observation Tests
  • Others
  • Others

By Treatment

  • Light Therapy (Phototherapy)
  • Bright Light Treatment
  • Dawn Simulation
  • Others
  • Medications
  • Antidepressants
  • Reuptake Inhibitors (SSRIs)
  • Paroxetine (Paxil)
  • Sertraline (Zoloft)
  • Bupropion (Wellbutrin)
  • Venlafaxine (Effexor)
  • Others
  • Others
  • Psychotherapy
  • Art Therapy
  • Attachment-Based Psychotherapy
  • Behavioral Therapy
  • Body Psychotherapy
  • Cognitive Analytical Therapy (CAT)
  • Existential Psychotherapy
  • Gestalt Therapy
  • Others
  • Counselling
  • Others

By End User

  • Hospital and Clinics
  • Academic Institutions
  • Medical Research Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape:

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the Seasonal Affective Disorder Market By Type, By Diagnosis, By Treatment, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics